Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 6:16 pm Purchase | 13G | Xencor Inc XNCR | EcoR1 Capital LLC | 6,719,304 9.400% | 1,436,788 (+27.20%) | View |
| 2024-11-14 1:22 pm Purchase | 13G | Xencor Inc XNCR | PRICE T ROWE ASSOCIATES INC | 3,929,062 5.600% | 439,160 (+12.58%) | View |
| 2024-11-12 4:01 pm Purchase | 13G | Xencor Inc XNCR | PRIMECAP MANAGEMENT CO | 9,137,195 13.080% | 235,588 (+2.65%) | View |
| 2024-11-08 2:17 pm Unchanged | 13G | Xencor Inc XNCR | BlackRock Inc. BLK | 11,026,330 15.800% | 0 (Unchanged) | View |
| 2024-10-21 4:18 pm Purchase | 13G | Zenas BioPharma Inc. ZBIO | Xencor Inc XNCR | 3,098,380 7.400% | 3,098,380 (New Position) | View |
| 2024-10-18 3:31 pm Sale | 13G | Xencor Inc XNCR | BlackRock Inc. BLK | 11,026,330 15.800% | -295,912 (-2.61%) | View |
| 2024-10-18 12:48 pm Sale | 13G | Xencor Inc XNCR | STATE STREET CORP STT | 3,119,290 4.500% | -207,566 (-6.24%) | View |
| 2024-10-02 4:50 pm Unchanged | 13G | Inmune Bio Inc. INMB | Xencor Inc XNCR | 1,885,533 9.600% | 0 (Unchanged) | View |
| 2024-02-16 5:43 pm Sale | 13G | Xencor Inc XNCR | T. Rowe Price Investment Management Inc. | 1,351,367 2.200% | -3,483,775 (-72.05%) | View |
| 2024-02-14 6:54 pm Unchanged | 13G | Xencor Inc XNCR | EcoR1 Capital LLC | 5,282,516 8.700% | 0 (Unchanged) | View |
| 2024-02-14 10:04 am Purchase | 13G | Xencor Inc XNCR | T. Rowe Price Investment Management Inc. | 4,835,142 2.200% | 1,100,072 (+29.45%) | View |
| 2024-02-14 10:03 am Purchase | 13G | Xencor Inc XNCR | PRICE T ROWE ASSOCIATES INC | 3,489,902 5.700% | 271,141 (+8.42%) | View |
| 2024-02-13 5:17 pm Purchase | 13G | Xencor Inc XNCR | VANGUARD GROUP INC | 6,767,249 11.120% | 115,016 (+1.73%) | View |
| 2024-02-12 4:01 pm Purchase | 13G | Xencor Inc XNCR | PRIMECAP MANAGEMENT CO | 8,901,607 14.620% | 2,684,704 (+43.18%) | View |
| 2024-02-09 10:05 am Sale | 13G | Xencor Inc XNCR | FMR LLC | 2,562,905 4.210% | -1,262,448 (-33.00%) | View |
| 2024-01-25 07:05 am Purchase | 13G | Xencor Inc XNCR | STATE STREET CORP STT | 3,326,856 5.470% | 170,805 (+5.41%) | View |
| 2024-01-19 2:40 pm Purchase | 13G | Xencor Inc XNCR | BlackRock Inc. BLK | 11,322,242 18.600% | 675,143 (+6.34%) | View |
| 2023-02-15 5:06 pm Unchanged | 13G | Inmune Bio Inc. INMB | Xencor Inc XNCR | 1,885,533 10.500% | 0 (Unchanged) | View |
| 2023-02-14 12:40 pm Purchase | 13G | Xencor Inc XNCR | T. Rowe Price Investment Management Inc. | 3,735,070 6.200% | 3,735,070 (New Position) | View |
| 2023-02-14 12:38 pm Sale | 13G | Xencor Inc XNCR | PRICE T ROWE ASSOCIATES INC | 3,218,761 5.400% | -2,689,922 (-45.52%) | View |